Growth Metrics

Alnylam Pharmaceuticals (ALNY) Cash from Operations (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -56.89%
Dec 31, 2025 -49.69%
Sep 30, 2025 108.77%
Jun 30, 2025 229.44%
Mar 31, 2025 -27.10%
Dec 31, 2024 -316.58%
Sep 30, 2024 -64.80%
Jun 30, 2024 252.31%
Mar 31, 2024 -173.59%
Dec 31, 2023 -108.29%
Sep 30, 2023 709.32%
Jun 30, 2023 64.57%
Mar 31, 2023 -26.14%
Dec 31, 2022 -14.48%
Sep 30, 2022 6.14%
Jun 30, 2022 28.26%
Mar 31, 2022 -14.02%
Dec 31, 2021 -12.02%
Sep 30, 2021 -10.00%
Jun 30, 2021 48.29%
Mar 31, 2021 -91.37%
Dec 31, 2020 -11.62%
Sep 30, 2020 18.48%
Jun 30, 2020 45.02%
Mar 31, 2020 -25.61%
Dec 31, 2019 -7.31%
Sep 30, 2019 -163.26%
Jun 30, 2019 253.15%
Mar 31, 2019 -25.29%
Dec 31, 2018 2.18%
Sep 30, 2018 -49.78%
Jun 30, 2018 34.03%
Mar 31, 2018 -51.07%
Dec 31, 2017 -4.76%
Sep 30, 2017 -21.36%
Jun 30, 2017 19.22%
Mar 31, 2017 -28.07%
Dec 31, 2016 -3.71%
Sep 30, 2016 -7.59%
Jun 30, 2016 16.05%
Mar 31, 2016 -57.59%
Dec 31, 2015 2.39%
Sep 30, 2015 1.97%
Jun 30, 2015 -111.22%
Mar 31, 2015 28.33%
Dec 31, 2014 10.00%
Sep 30, 2014 12.69%
Jun 30, 2014 -11.88%
Mar 31, 2014 -86.31%
Dec 31, 2013 -3.01%
Sep 30, 2013 8.00%
Jun 30, 2013 -2,330.69%
Mar 31, 2013 98.59%
Dec 31, 2012 -1,422.18%
Sep 30, 2012 124.03%
Jun 30, 2012 28.20%
Mar 31, 2012 -20.10%
Dec 31, 2011 13.32%
Sep 30, 2011 -9.20%
Jun 30, 2011 -321.55%
Mar 31, 2011 69.07%
Dec 31, 2010 15.18%
Sep 30, 2010 1.14%
Jun 30, 2010 -55.85%
Mar 31, 2010 7.52%
Dec 31, 2009 18.06%